Tag: Scleroderma and Raynaud’s UK (SRUK)

  • Beyond the Skin-Pinch Test for Scleroderma

    Beyond the Skin-Pinch Test for Scleroderma

    —

    by

    Andy Burnett
    in , ,

    Researchers blame a low-tech skin-pinch test, in part, for the routine failure of potential scleroderma drugs in clinical trials. Modernizing the evaluation of potential drug therapies was the focus of the three-day Scleroderma Diagnosis Sandpit hosted by Scleroderma and Raynaud’s UK February 26-28, 2020 at the Wellcome Collection in London.